| Literature DB >> 33460507 |
Francesco Cavallieri1,2, Francesca Sireci1, Valentina Fioravanti1, Giulia Toschi1, Vittorio Rispoli3, Francesca Antonelli3, Massimo Costantini4, Luca Ghirotto5, Franco Valzania1.
Abstract
BACKGROUND ANDEntities:
Keywords: COVID-19; needs; Parkinson's disease; qualitative analysis; qualitative research
Mesh:
Year: 2021 PMID: 33460507 PMCID: PMC8014253 DOI: 10.1111/ene.14745
Source DB: PubMed Journal: Eur J Neurol ISSN: 1351-5101 Impact factor: 6.288
Participant characteristics
| Variable | Patients | CGs | Total | |||
|---|---|---|---|---|---|---|
|
| % |
| % |
| % | |
| Age | ||||||
| 41–50 years | 3/67 | 4.48 | 0/36 | 0.00 | 3/103 | 2.91 |
| 51–60 years | 15/67 | 22.39 | 1/36 | 2.78 | 16/103 | 15.53 |
| 61–70 years | 39/67 | 58.21 | 15/36 | 41.66 | 54/103 | 52.42 |
| 71–80 years | 10/67 | 14.92 | 12/36 | 33.33 | 22/103 | 21.35 |
| >80 years | 0/67 | 0.00 | 8/36 | 22.22 | 8/103 | 7.76 |
| Gender | ||||||
| Female | 26/67 | 38.80 | 14/36 | 38.89 | 40/103 | 38.83 |
| Male | 41/67 | 61.20 | 22/36 | 61.11 | 63/103 | 61.17 |
| Italian region of provenance | ||||||
| Emilia Romagna | 61/67 | 91.03 | 35/36 | 97.22 | 96/103 | 93.20 |
| Lombardy | 3/67 | 4.48 | 0/36 | 0.00 | 3/103 | 2.91 |
| Piedmont | 1/67 | 1.50 | 0/36 | 0.00 | 1/103 | 0.97 |
| Veneto | 2/67 | 2.99 | 1/36 | 2.78 | 3/103 | 2.91 |
| PD duration | ||||||
| <2 years | 6/67 | 8.95 | 5/36 | 13.88 | 11/103 | 10.67 |
| 2–5 years | 17/67 | 25.38 | 11/36 | 30.56 | 28/103 | 27.18 |
| >5 years | 44/67 | 65.67 | 20/36 | 55.56 | 64/103 | 62.13 |
| PD treatment | ||||||
| No | 2/67 | 2.99 | 1/36 | 2.78 | 3/103 | 2.92 |
| Yes | 65/67 | 97.01 | 35/36 | 97.22 | 100/103 | 97.08 |
| Treatment type | ||||||
| Pharmacologic treatment | 48/67 | 73.84 | 31/36 | 88.57 | 79/103 | 79 |
| Deep brain stimulation | 17/67 | 26.16 | 4/36 | 11.43 | 21/103 | 21 |
| Subjected to quarantine | ||||||
| No | 64/67 | 95.52 | 35/36 | 97.22 | 99/103 | 96.12 |
| Yes | 3/67 | 4.48 | 1/36 | 2.78 | 4/103 | 3.88 |
Abbreviations: CG, caregiver; PD, Parkinson's disease.
Participant responses to the core open‐ended questions
| What are the needs related to PD, which risk not being satisfied in this pandemic period? | ||||||
|---|---|---|---|---|---|---|
| Unmet needs during the pandemic period | Patients (respondents: 67/67, 100%) | CGs (respondents: 36/36, 100%) | Total (respondents: 103/103, 100%) | |||
|
| % |
| % |
| % | |
| Physical activity | 35/67 | 52.24 | 22/36 | 61.11 | 57/103 | 55.03 |
| Access to outpatient visits | 14/67 | 20.9 | 12/36 | 33.33 | 26/103 | 25.24 |
| Socialization | 7/67 | 10.45 | 3/36 | 8.33 | 10/103 | 9.71 |
| Access to support services | 3/67 | 4.48 | 2/36 | 5.56 | 5/103 | 4.85 |
| Medication dosage control | 2/67 | 2.99 | 1/36 | 2.78 | 3/103 | 2.91 |
| No unmet needs | 6/67 | 8.96 | 0/36 | 0.00 | 6/103 | 5.83 |
Abbreviations: CG, caregiver; PD, Parkinson's disease.